Relative Bioavailability of Intravenous GTX-104 Compared to Oral Nimodipine Capsules in Healthy Subjects

Clinical trial NCT05418348 · COMPLETED

Trial details

NCT number: NCT05418348
Sponsor: Grace Therapeutics Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Aneurysmal Subarachnoid Hemorrhage

Start date: 2021-08-26
Primary completion: 2022-02-17
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.